Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

MiR-155-mediated loss of C/EBP beta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer

Johansson, J. ; Berg, T. ; Kurzejamska, E. ; Pang, M-F ; Tabor, V. ; Jansson, M. ; Roswall, P. ; Pietras, Kristian LU orcid ; Sund, M. and Religa, P. , et al. (2013) In Oncogene 32(50). p.5614-5624
Abstract
During breast cancer progression, transforming growth factor-beta (TGF-beta) switches from acting as a growth inhibitor to become a major promoter of epithelial-mesenchymal transition (EMT), invasion and metastasis. However, the mechanisms involved in this switch are not clear. We found that loss of CCAAT-enhancer binding protein beta (C/EBP beta), a differentiation factor for the mammary epithelium, was associated with signs of EMT in triple-negative human breast cancer, and in invasive areas of mammary tumors in MMTV-PyMT mice. Using an established model of TGF-beta-induced EMT in mouse mammary gland epithelial cells, we discovered that C/EBP beta was repressed during EMT by miR-155, an oncomiR in breast cancer. Depletion of C/EBP beta... (More)
During breast cancer progression, transforming growth factor-beta (TGF-beta) switches from acting as a growth inhibitor to become a major promoter of epithelial-mesenchymal transition (EMT), invasion and metastasis. However, the mechanisms involved in this switch are not clear. We found that loss of CCAAT-enhancer binding protein beta (C/EBP beta), a differentiation factor for the mammary epithelium, was associated with signs of EMT in triple-negative human breast cancer, and in invasive areas of mammary tumors in MMTV-PyMT mice. Using an established model of TGF-beta-induced EMT in mouse mammary gland epithelial cells, we discovered that C/EBP beta was repressed during EMT by miR-155, an oncomiR in breast cancer. Depletion of C/EBP beta potentiated the TGF-beta response towards EMT, and contributed to evasion of the growth inhibitory response to TGF-beta. Furthermore, loss of C/EBP beta enhanced invasion and metastatic dissemination of the mouse mammary tumor cells to the lungs after subcutaneous injection into mice. The mechanism by which loss of C/EBP beta promoted the TGF-beta response towards EMT, invasion and metastasis, was traced to a previously uncharacterized role of C/EBP beta as a transcriptional activator of genes encoding the epithelial junction proteins E-cadherin and coxsackie virus and adenovirus receptor. The results identify miR-155-mediated loss of C/EBP beta as a mechanism, which promotes breast cancer progression by shifting the TGF-beta response from growth inhibition to EMT, invasion and metastasis. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
CCAAT-enhancer binding protein beta, epithelial-mesenchymal transition, transforming growth factor-beta, Breast cancer, metastasis
in
Oncogene
volume
32
issue
50
pages
5614 - 5624
publisher
Nature Publishing Group
external identifiers
  • wos:000328461400006
  • scopus:84890572219
  • pmid:23955085
ISSN
1476-5594
DOI
10.1038/onc.2013.322
language
English
LU publication?
yes
id
b4402852-90f5-4d50-950c-ea3699c6f376 (old id 4272353)
date added to LUP
2016-04-01 09:52:38
date last changed
2022-02-02 03:43:40
@article{b4402852-90f5-4d50-950c-ea3699c6f376,
  abstract     = {{During breast cancer progression, transforming growth factor-beta (TGF-beta) switches from acting as a growth inhibitor to become a major promoter of epithelial-mesenchymal transition (EMT), invasion and metastasis. However, the mechanisms involved in this switch are not clear. We found that loss of CCAAT-enhancer binding protein beta (C/EBP beta), a differentiation factor for the mammary epithelium, was associated with signs of EMT in triple-negative human breast cancer, and in invasive areas of mammary tumors in MMTV-PyMT mice. Using an established model of TGF-beta-induced EMT in mouse mammary gland epithelial cells, we discovered that C/EBP beta was repressed during EMT by miR-155, an oncomiR in breast cancer. Depletion of C/EBP beta potentiated the TGF-beta response towards EMT, and contributed to evasion of the growth inhibitory response to TGF-beta. Furthermore, loss of C/EBP beta enhanced invasion and metastatic dissemination of the mouse mammary tumor cells to the lungs after subcutaneous injection into mice. The mechanism by which loss of C/EBP beta promoted the TGF-beta response towards EMT, invasion and metastasis, was traced to a previously uncharacterized role of C/EBP beta as a transcriptional activator of genes encoding the epithelial junction proteins E-cadherin and coxsackie virus and adenovirus receptor. The results identify miR-155-mediated loss of C/EBP beta as a mechanism, which promotes breast cancer progression by shifting the TGF-beta response from growth inhibition to EMT, invasion and metastasis.}},
  author       = {{Johansson, J. and Berg, T. and Kurzejamska, E. and Pang, M-F and Tabor, V. and Jansson, M. and Roswall, P. and Pietras, Kristian and Sund, M. and Religa, P. and Fuxe, J.}},
  issn         = {{1476-5594}},
  keywords     = {{CCAAT-enhancer binding protein beta; epithelial-mesenchymal transition; transforming growth factor-beta; Breast cancer; metastasis}},
  language     = {{eng}},
  number       = {{50}},
  pages        = {{5614--5624}},
  publisher    = {{Nature Publishing Group}},
  series       = {{Oncogene}},
  title        = {{MiR-155-mediated loss of C/EBP beta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer}},
  url          = {{http://dx.doi.org/10.1038/onc.2013.322}},
  doi          = {{10.1038/onc.2013.322}},
  volume       = {{32}},
  year         = {{2013}},
}